Cited by 1,788Chronic Kidney Disease and DiabetesDialysis and Renal Disease ManagementClinical practice guidelines implementation

KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease

Open access
·2007·American Journal of Kidney Diseases

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.ajkd.2006.12.005

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In developed countries, diabetes is the leading cause of chronic kidney disease, and in the United States, accounts for nearly half of all kidney failure.

    “In developed countries, diabetes is the leading cause of chronic kidney disease, and in the United States, accounts for nearly half of all kidney failure.100”

    From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [100]

    The Background (page unavailable) says diabetes is the most common cause of kidney failure in the United States and among the most common causes elsewhere. It does not establish that diabetes is the leading cause of chronic kidney disease specifically in developed countries or give the claimed nearly-half share of US kidney failure. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • KDOQI guidelines call for adults with chronic kidney disease and diabetes to follow the same low-protein diets (0.8 g protein/kg body weight per day) as people with chronic kidney disease, although there is little evidence for adults older than 75.

    “Accordingly, the Kidney Disease Outcomes Quality Initiative of the American National Kidney Foundation (KDOQI) guidelines call for adults with chronic kidney disease (CKD) and diabetes to follow the same low-protein diets (0.8 g protein/kg BW/d) as people with CKD, although there is little evidence for adults older than 75.”

    From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [100]

    Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Most longitudinal cohort studies report significant increases in the prevalence of moderately increased albuminuria only after type 1 diabetes has been present for 5 years.

    “Most longitudinal cohort studies report significant increases in the prevalence of moderately increased albuminuria only after type 1 diabetes has been present for 5 years (456,457).”
  • ACR has marked variability; therefore, a confirmatory urine sample within 3-6 months is recommended.

    “ACR has marked variability; therefore, a confirmatory urine sample within 3–6 months is recommended (26,27).”
  • Most longitudinal cohort studies have reported significant increases in the prevalence of low levels of albuminuria only after diabetes has been present for 5 years.

    “Of note is that most longitudinal cohort studies have reported significant increases in the prevalence of low levels of albuminuria only after diabetes has been present for 5 years (326,336).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 14

  1. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S13-S19
  2. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S21-S41
  3. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S42-S61
  4. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S62-S73
  5. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S74-S87
  6. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S88-S94
  7. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S95-S107
  8. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S109-S115
  9. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S116-S119
  10. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S120-S130
  11. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S131-S138
  12. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S140-S143
  13. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S144-S147
  14. American Journal of Kidney Diseases, Vol 49, No 2, Suppl 2 (February), 2007: pp S148-S154

Cited by

Sorted by citations

Venue
American Journal of Kidney Diseases
Publisher
Elsevier BV
Published
2007-02
Volume
49
Issue
2
Pages
S12-S154
ISSN
0272-6386 (ISSN-L)
OpenAlex
W2042689611
Cited by
1,788
References
2
Citations by year
2026: 21 · 2025: 44 · 2024: 64 · 2023: 74 · 2022: 99 · 2021: 90 · 2020: 85 · 2019: 84 · 2018: 71 · 2017: 101 · 2016: 87 · 2015: 133 · 2014: 136 · 2013: 144 · 2012: 106
FWCI
77.30
Type
journal article
Language
en
Open access
Locations
  • American Journal of Kidney Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords
chronic kidney disease, diabetes mellitus, clinical guidelines, renal replacement therapy, cardiovascular risk, renal failure, cardiovascular risk in CKD
MeSH terms
Chronic Disease, Diabetes Mellitus, Humans, Kidney Diseases, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review